Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80,854 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A single-institution phase I feasibility study of dose-escalated IMRT for non-operative locally advanced esophageal carcinoma.
Vlacich G, Ballard A, Badiyan SN, Spraker M, Henke L, Kim H, Lockhart AC, Park H, Suresh R, Huang Y, Robinson CG, Bradley JD, Samson PP. Vlacich G, et al. Among authors: huang y. Clin Transl Radiat Oncol. 2021 Jun 29;30:19-25. doi: 10.1016/j.ctro.2021.06.007. eCollection 2021 Sep. Clin Transl Radiat Oncol. 2021. PMID: 34278011 Free PMC article.
Nonoperative Rectal Cancer Management With Short-Course Radiation Followed by Chemotherapy: A Nonrandomized Control Trial.
Kim H, Pedersen K, Olsen JR, Mutch MG, Chin RI, Glasgow SC, Wise PE, Silviera ML, Tan BR, Wang-Gillam A, Lim KH, Suresh R, Amin M, Huang Y, Henke LE, Park H, Ciorba MA, Badiyan S, Parikh PJ, Roach MC, Hunt SR. Kim H, et al. Among authors: huang y. Clin Colorectal Cancer. 2021 Sep;20(3):e185-e193. doi: 10.1016/j.clcc.2021.03.003. Epub 2021 Apr 7. Clin Colorectal Cancer. 2021. PMID: 34001462 Clinical Trial.
Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis.
Roy A, Brenneman RJ, Hogan J, Barnes JM, Huang Y, Morris R, Goddu S, Altman M, Garcia-Ramirez J, Li H, Zoberi JE, Bullock A, Kim E, Smith Z, Figenshau R, Andriole GL, Baumann BC, Michalski JM, Gay HA. Roy A, et al. Among authors: huang y. Clin Transl Radiat Oncol. 2021 May 13;29:47-53. doi: 10.1016/j.ctro.2021.05.004. eCollection 2021 Jul. Clin Transl Radiat Oncol. 2021. PMID: 34136665 Free PMC article.
Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.
Szymanski JJ, Sundby RT, Jones PA, Srihari D, Earland N, Harris PK, Feng W, Qaium F, Lei H, Roberts D, Landeau M, Bell J, Huang Y, Hoffman L, Spencer M, Spraker MB, Ding L, Widemann BC, Shern JF, Hirbe AC, Chaudhuri AA. Szymanski JJ, et al. Among authors: huang y. PLoS Med. 2021 Aug 31;18(8):e1003734. doi: 10.1371/journal.pmed.1003734. eCollection 2021 Aug. PLoS Med. 2021. PMID: 34464388 Free PMC article.
Clinical Complete Response in Patients With Rectal Adenocarcinoma Treated With Short-Course Radiation Therapy and Nonoperative Management.
Chin RI, Roy A, Pedersen KS, Huang Y, Hunt SR, Glasgow SC, Tan BR, Wise PE, Silviera ML, Smith RK, Suresh R, Badiyan SN, Shetty AS, Henke LE, Mutch MG, Kim H. Chin RI, et al. Among authors: huang y. Int J Radiat Oncol Biol Phys. 2022 Mar 1;112(3):715-725. doi: 10.1016/j.ijrobp.2021.10.004. Epub 2021 Oct 12. Int J Radiat Oncol Biol Phys. 2022. PMID: 34653579
Oligometastatic Rectal Adenocarcinoma Treated With Short-Course Radiation Therapy and Chemotherapy With Nonoperative Intent of the Primary for Locoregional Complete Responders.
Schiff JP, Chin RI, Roy A, Mahapatra L, Stowe HB, Andruska N, Huang Y, Mutch M, Fields RC, Hawkins WG, Doyle M, Chapman W, Tan B, Henke LE, Badiyan SN, DeSelm C, Samson PP, Pedersen K, Kim H. Schiff JP, et al. Among authors: huang y. Pract Radiat Oncol. 2022 Sep-Oct;12(5):e406-e414. doi: 10.1016/j.prro.2022.04.008. Epub 2022 May 5. Pract Radiat Oncol. 2022. PMID: 35526826
Clinical Outcomes of Patients With Unresectable Primary Liver Cancer Treated With Yttrium-90 Radioembolization With an Escalated Dose.
Chin RI, Bommireddy A, Fraum TJ, Ludwig DR, Huang Y, Zoberi JE, Garcia-Ramirez JL, Maughan NM, Chapman W, Korenblat K, Henke LE, Kim H, Badiyan SN. Chin RI, et al. Among authors: huang y. Adv Radiat Oncol. 2022 Mar 21;7(4):100948. doi: 10.1016/j.adro.2022.100948. eCollection 2022 Jul-Aug. Adv Radiat Oncol. 2022. PMID: 35814852 Free PMC article.
80,854 results
You have reached the last available page of results. Please see the User Guide for more information.